1.Oxidative stress and Alzheimer's disease
Yeye ZHUO ; Hanting ZHANG ; Jiangping XU
Chinese Pharmacological Bulletin 2010;26(4):435-437
Alzheimer's disease(AD)is a progressive neurodegenerative disease characterized by cognition impairment and behavioral abnormalities.While the mechanisms involved in AD remain unclear,various hypotheses have been proposed regarding pathogenesis of AD,among which the oxidative stress hypothesis has attracted more and more attention.In the present article,the relationship between oxidative stress and AD is reviewed,including sources of neuronal oxygen radical generation,the link of oxidative stress to pathogenesis of AD,preclinical and clinical studies of AD,therapeutic effects of antioxidants and phosphodiesterase inhibitors on AD.
2.Accelerating the professional clinical research team building in the process of transforming towards research-oriented hospitals
Lijun ZHU ; Shani CHENG ; Hao WANG ; Yeye DU ; Wanrong PAN ; Xiaojing XU ; Huijun LIU ; Shansheng ZHOU ; Haiying ZHU ; Shan MOU ; Jianzheng ZHU
Journal of Shanghai Jiaotong University(Medical Science) 2017;37(6):715-718
Building a professional clinical research team inside hospitals is in favor improving their research abilities,accelerating the clinical discipline construction,improving their comprehensive influence.Also it fits the objective of general hospital development under gate-keeping system.Now in domestic,the percentage of professional research staff in large hospitals accounts was much less than the international level.The main reasons included the misunderstanding of constructing the research-oriented hospitals,insufficient human resources enrollment,less attractive environment to the highlevel researchers and the absence of relevant degree training programs.To enhance the construction of research-oriented hospitals,it's of key importance to build the professional research team in hospitals.Besides,the hospital has to update management conception,broaden the channels of talent cultivation,grasp the development of the subject accurately and interact with the basic medicine and public health subject,increase the financial investment and perfect the relevant management regulations.
3.CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics.
Jian LU ; Jie LIU ; Yuanqing GUO ; Yuanjin ZHANG ; Yeye XU ; Xin WANG
Acta Pharmaceutica Sinica B 2021;11(10):2973-2982
The 2020 Nobel Prize in Chemistry recognized CRISPR-Cas9, a super-selective and precise gene editing tool. CRISPR-Cas9 has an obvious advantage in editing multiple genes in the same cell, and presents great potential in disease treatment and animal model construction. In recent years, CRISPR-Cas9 has been used to establish a series of rat models of drug metabolism and pharmacokinetics (DMPK), such as
4.NETO2 promotes melanoma progression via activation of the Ca2+/CaMKII signaling pathway.
Susi ZHU ; Xu ZHANG ; Yeye GUO ; Ling TANG ; Zhe ZHOU ; Xiang CHEN ; Cong PENG
Frontiers of Medicine 2023;17(2):263-274
Melanoma is the most aggressive cutaneous tumor. Neuropilin and tolloid-like 2 (NETO2) is closely related to tumorigenesis. However, the functional significance of NETO2 in melanoma progression remains unclear. Herein, we found that NETO2 expression was augmented in melanoma clinical tissues and associated with poor prognosis in melanoma patients. Disrupting NETO2 expression markedly inhibited melanoma proliferation, malignant growth, migration, and invasion by downregulating the levels of calcium ions (Ca2+) and the expression of key genes involved in the calcium signaling pathway. By contrast, NETO2 overexpression had the opposite effects. Importantly, pharmacological inhibition of CaMKII/CREB activity with the CaMKII inhibitor KN93 suppressed NETO2-induced proliferation and melanoma metastasis. Overall, this study uncovered the crucial role of NETO2-mediated regulation in melanoma progression, indicating that targeting NETO2 may effectively improve melanoma treatment.
Humans
;
Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism*
;
Cell Line, Tumor
;
Cell Proliferation
;
Melanoma/genetics*
;
Membrane Proteins/genetics*
;
Phosphorylation
;
Signal Transduction